Replies to post #1077 on Israel-Medical-Healthcare

[genisi]

Can-Fite (TASE:CFBI; OTC:CANFY)

CF101 Psoriasis Phase II/III quantitative interim results, see slide 12 in the presentation:

http://www.canfite.co.il/upload/2012-12-30_Can-Fite_Overview-English_isa.pdf

Not stat-sig vs placebo at 12 weeks with data from 103 patients, but with additional 188 patients I think it will be.
One odd observation: placebo switchers improved as soon as being put on the 2 mg drug (too quickly) after week 12.
The PR:

http://www.canfite.co.il/upload/2012-12-30%20Psoriasis%20additional%20analysis%20-%20English.pdf